Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ) Short Interest Update

Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ) saw a significant decrease in short interest in February. As of February 27th, there was short interest totaling 10,141 shares, a decrease of 50.5% from the February 12th total of 20,471 shares. Approximately 0.4% of the shares of the stock are sold short. Based on an average daily volume of 18,389 shares, the days-to-cover ratio is currently 0.6 days. Based on an average daily volume of 18,389 shares, the days-to-cover ratio is currently 0.6 days. Approximately 0.4% of the shares of the stock are sold short.

Institutional Investors Weigh In On Invesco Nasdaq Biotechnology ETF

Several large investors have recently added to or reduced their stakes in IBBQ. WMS Group LLC purchased a new stake in Invesco Nasdaq Biotechnology ETF during the fourth quarter valued at approximately $4,255,000. LPL Financial LLC purchased a new position in shares of Invesco Nasdaq Biotechnology ETF in the 4th quarter worth approximately $1,220,000. Independent Advisor Alliance purchased a new position in shares of Invesco Nasdaq Biotechnology ETF in the 4th quarter worth approximately $653,000. GeoWealth Management LLC bought a new position in shares of Invesco Nasdaq Biotechnology ETF during the 3rd quarter valued at approximately $451,000. Finally, Mirae Asset Global Investments Co. Ltd. raised its holdings in Invesco Nasdaq Biotechnology ETF by 7.3% during the 3rd quarter. Mirae Asset Global Investments Co. Ltd. now owns 215,722 shares of the company’s stock valued at $5,245,000 after buying an additional 14,717 shares during the period.

Invesco Nasdaq Biotechnology ETF Stock Performance

Shares of NASDAQ:IBBQ traded down $0.81 on Thursday, reaching $28.58. The company’s stock had a trading volume of 16,436 shares, compared to its average volume of 42,097. The company has a 50-day simple moving average of $29.32 and a 200 day simple moving average of $27.34. Invesco Nasdaq Biotechnology ETF has a 52-week low of $17.84 and a 52-week high of $30.49. The company has a market cap of $71.74 million, a P/E ratio of 17.03 and a beta of 0.67.

Invesco Nasdaq Biotechnology ETF Cuts Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, December 26th. Investors of record on Monday, December 22nd were issued a $0.0906 dividend. The ex-dividend date of this dividend was Monday, December 22nd. This represents a $0.36 dividend on an annualized basis and a dividend yield of 1.3%.

About Invesco Nasdaq Biotechnology ETF

The Invesco Nasdaq Biotechnology ETF (IBBQ) is an exchange-traded fund that is based on the NASDAQ / Biotechnology index, a modified market-cap-weighted index of US biotechnology and pharmaceutical companies listed on the NASDAQ. IBBQ was launched on Jun 11, 2021 and is managed by Invesco.